ARTICLE | Clinical News
Provigil modafinil regulatory update
November 1, 2010 7:00 AM UTC
FDA approved a REMS for Provigil modafinil from Cephalon to inform patients about the potential risks associated with its use, including serious skin rash and hypersensitivity reactions. The REMS cons...